United States · FDA National Drug Code directory

EVEROLIMUS

Source ingredient · 99 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.

United States · Source reference 70377-090_7f7c486a-aefb-4798-aa9f-365799886a72

Everolimus

TABLET, FOR SUSPENSION / Biocon Pharma Inc.

United States · Source reference 70377-091_7f7c486a-aefb-4798-aa9f-365799886a72

Everolimus

TABLET, FOR SUSPENSION / Biocon Pharma Inc.

United States · Source reference 70377-092_7f7c486a-aefb-4798-aa9f-365799886a72

Everolimus

TABLET, FOR SUSPENSION / Biocon Pharma Inc.

United States · Source reference 70377-112_7aa24558-b2a2-ed22-b6bc-69a011d2511a

Everolimus

TABLET / Biocon Pharma Inc.

United States · Source reference 72319-003_5afb5d8b-631c-48bd-e063-6294a90acfe3

Everolimus

TABLET / i3 Pharmaceuticals, LLC

United States · Source reference 72319-015_5afb5d8b-631c-48bd-e063-6294a90acfe3

Everolimus

TABLET / i3 Pharmaceuticals, LLC

United States · Source reference 72319-016_5afb5d8b-631c-48bd-e063-6294a90acfe3

Everolimus

TABLET / i3 Pharmaceuticals, LLC

United States · Source reference 72319-017_5afb5d8b-631c-48bd-e063-6294a90acfe3

Everolimus

TABLET / i3 Pharmaceuticals, LLC

United States · Source reference 0245-0822_53e82eaf-5985-55b3-e063-6394a90a673a

TORPENZ

TABLET / Upsher-Smith Laboratories, LLC

United States · Source reference 0245-0823_53e82eaf-5985-55b3-e063-6394a90a673a

TORPENZ

TABLET / Upsher-Smith Laboratories, LLC

United States · Source reference 0245-0824_53e82eaf-5985-55b3-e063-6394a90a673a

TORPENZ

TABLET / Upsher-Smith Laboratories, LLC

United States · Source reference 0245-0825_53e82eaf-5985-55b3-e063-6394a90a673a

TORPENZ

TABLET / Upsher-Smith Laboratories, LLC

United States · Source reference 82249-610_01d9a611-3216-427b-a18a-15366572b3d3

Yulithira

TABLET / CivicaScript, LLC

United States · Source reference 82249-611_01d9a611-3216-427b-a18a-15366572b3d3

Yulithira

TABLET / CivicaScript, LLC

United States · Source reference 82249-612_01d9a611-3216-427b-a18a-15366572b3d3

Yulithira

TABLET / CivicaScript, LLC

United States · Source reference 82249-613_01d9a611-3216-427b-a18a-15366572b3d3

Yulithira

TABLET / CivicaScript, LLC

United States · Source reference 0078-0414_5b9ba6f0-1e1d-4b9c-9122-ad856284d7ca

Zortress

TABLET / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0415_5b9ba6f0-1e1d-4b9c-9122-ad856284d7ca

Zortress

TABLET / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0417_5b9ba6f0-1e1d-4b9c-9122-ad856284d7ca

Zortress

TABLET / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0422_5b9ba6f0-1e1d-4b9c-9122-ad856284d7ca

Zortress

TABLET / Novartis Pharmaceuticals Corporation

United States · Source reference 17088-0107_4b824672-827a-46a1-a55e-d12233f7383a

everolimus

TABLET, FOR SUSPENSION / Novartis Pharma Stein AG

United States · Source reference 17088-0114_4b824672-827a-46a1-a55e-d12233f7383a